通过抑制E2F-DP二分化,20(S) - 丁化物Rg3抑制了胃癌细胞的增殖
Fuqiang Li1, Chengyu Cai2, Fei Wang2
1School of Life Sciences, Jilin University, 2699 Qianjin Street, Chaoyang District, Changchun, Jilin 130012, China; School of Pharmacy, Changchun University of Chinese Medicine, Boshuo Road, Jingyue Development Zone, Changchun, Jilin 130117, China.
金色化物Rg3直接与E2F结合,通过破坏E2F-DP形成和激活瘤抑制剂来抑制胃癌细胞的增殖. 这揭示了针对高E2F表达的瘤的潜在治疗策略.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃癌 (GC) 是具有侵略性的,由于耐药性,治疗选择有限.
- 金色化物Rg3显示出抗瘤潜力,但其在GC中的机制尚不清楚.
研究的目的:
- 阐明人参酸Rg3在胃癌中的抗癌作用的分子机制.
- 研究Rg3与E2F的相互作用及其对细胞增殖和细胞亡的下游影响.
主要方法:
- RNA测序 (RNA-Seq) 用于识别Rg3调节的标.
- 包括CETSA,拉下,质谱和分子对接在内的测试以确认Rg3-E2F相互作用.
- qRT-PCR,西式涂抹和流细胞计,以分析细胞周期和细胞亡的分子效应.
主要成果:
- Rg3抑制E2F的表达,诱导G1/S细胞周期的停止,并抑制GC的增殖在体外和体内.
- 证实了Rg3与E2F的直接结合,破坏了E2F-DP异构体的形成和下游基因转录.
- Rg3激活p53/p21并抑制循环/CDK-RB信号传递,阻断G1/S过渡.
结论:
- Rg3直接准E2F,通过破坏E2F-DP和激活p53/p21来抑制胃癌细胞的增殖.
- Rg3抑制了环林/CDK-RB通路,为GC提供了一个新的治疗策略.
- 与Rg3相似的小分子可以准表达E2F的瘤.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
相关概念视频
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Positive Regulator Molecules
Inhibition of Cdk Activity
Negative Regulator Molecules
Abnormal Proliferation
